https://scholars.lib.ntu.edu.tw/handle/123456789/543447
標題: | Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: A JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS | 作者: | Muro K. Van Cutsem E. Narita Y. Pentheroudakis G. Baba E. Li J. Ryu M.-H. Wan Zamaniah W.I. Yong W.-P. KUN-HUEI YEH Kato K. Lu Z. Cho B.C. Nor I.M. Ng M. Chen L.-T. Nakajima T.E. Shitara K. Kawakami H. Tsushima T. Yoshino T. Lordick F. Martinelli E. Smyth E.C. Arnold D. Minami H. Tabernero J. Douillard J.-Y. |
關鍵字: | Consensus; ESMO guidelines; Metastatic gastric cancer; Pan-Asian | 公開日期: | 2019 | 出版社: | Oxford University Press | 卷: | 30 | 期: | 1 | 起(迄)頁: | 19-33 | 來源出版物: | Annals of Oncology | 摘要: | The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of gastric cancer (GC) was published in 2016, and covered the management and treatment of local, locoregional, locally advanced and metastatic disease. At the ESMO Asia Meeting in November 2017 it was decided by both ESMO and The Japanese Society of Medical Oncology (JSMO) to convene a special guidelines meeting immediately after the JSMO Annual Meeting in 2018. The aim was to adapt the ESMO 2016 guidelines to take into account the ethnic differences associated with the treatment of metastatic GC in Asian patients. These guidelines represent the consensus opinions reached by experts in the treatment of patients with metastatic GC representing the oncological societies of Japan (JSMO), China (CSCO), Korea (KSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence and was independent of both the current treatment practices and the drug availability and reimbursement situations in the individual participating Asian countries. ? The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060128881&doi=10.1093%2fannonc%2fmdy502&partnerID=40&md5=a864c55d1d9d1e90ec72acda42603624 https://scholars.lib.ntu.edu.tw/handle/123456789/543447 |
ISSN: | 0923-7534 | DOI: | 10.1093/annonc/mdy502 | SDG/關鍵字: | antineoplastic agent; advanced cancer; Article; Asia; Asian; cancer chemotherapy; cancer diagnosis; cancer localization; cancer patient; cancer radiotherapy; cancer surgery; China; consensus development; elderly care; ethnic difference; Europe; evidence based practice; follow up; hereditary tumor syndrome; histopathology; human; Japan; Malaysia; medical decision making; medical expert; medical society; metastasis potential; oncology; patient care; personalized medicine; pharmaceutical care; practice guideline; priority journal; Singapore; South Korea; stomach cancer; stomach surgery; systemic therapy; Taiwan; consensus; disease management; practice guideline; stomach tumor; Asia; Consensus; Disease Management; Humans; Practice Guidelines as Topic; Societies, Medical; Stomach Neoplasms |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。